chlorpromazine has been researched along with Dyskinesia, Drug-Induced in 96 studies
Chlorpromazine: The prototypical phenothiazine antipsychotic drug. Like the other drugs in this class chlorpromazine's antipsychotic actions are thought to be due to long-term adaptation by the brain to blocking DOPAMINE RECEPTORS. Chlorpromazine has several other actions and therapeutic uses, including as an antiemetic and in the treatment of intractable hiccup.
chlorpromazine : A substituted phenothiazine in which the ring nitrogen at position 10 is attached to C-3 of an N,N-dimethylpropanamine moiety.
Dyskinesia, Drug-Induced: Abnormal movements, including HYPERKINESIS; HYPOKINESIA; TREMOR; and DYSTONIA, associated with the use of certain medications or drugs. Muscles of the face, trunk, neck, and extremities are most commonly affected. Tardive dyskinesia refers to abnormal hyperkinetic movements of the muscles of the face, tongue, and neck associated with the use of neuroleptic agents (see ANTIPSYCHOTIC AGENTS). (Adams et al., Principles of Neurology, 6th ed, p1199)
| Excerpt | Relevance | Reference |
|---|---|---|
| "This pooled analysis of four 6-week, randomized, open-label, parallel trials of patients with schizophrenia (Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition) compared the efficacy and tolerability of olanzapine (5-20 mg/d) with those of chlorpromazine (200-800 mg/d)." | 9.12 | Olanzapine versus chlorpromazine in the treatment of schizophrenia: a pooled analysis of four 6-week, randomized, open-label studies in the Middle East and North Africa. ( Dominguez, S; Dossenbach, M; Huang, X; Kryzhanovskaya, L; Saylan, M; Treuer, T, 2007) |
| "Patients with acute exacerbation of schizophrenia (DSM-III-R criteria; n = 158) were allocated on a random, double-blind basis to receive zotepine (150 or 300 mg/day), chlorpromazine (300 or 600 mg/day) or placebo for 8 weeks." | 9.09 | A placebo-controlled comparison of zotepine versus chlorpromazine in patients with acute exacerbation of schizophrenia. ( Butler, A; Cooper, SJ; Raniwalla, J; Tweed, J; Welch, C, 2000) |
| "We have observed two cases of chlorpromazine-induced neuroleptic malignant syndrome (NMS); both were transiently responsive to intravenous diazepam challenge, but not to blind placebo or amyobarbitol." | 9.05 | Chlorpromazine-induced neuroleptic malignant syndrome and its response to diazepam. ( Lew, TY; Tollefson, G, 1983) |
| "A four week double-blind study comparing pimozide and chlorpromazine was designed to test the hypothesis that pimozide, a powerful dopamine receptor blocker, is more effective in the treatment of acute schizophrenia than chlorpromazine." | 9.05 | Comparison of pimozide and chlorpromazine in acute schizophrenia. ( Allan, T; McClure, DJ; Pecknold, JC; Wrzesinski, L, 1982) |
| "To determine the clinical effects, safety and cost-effectiveness of chlorpromazine compared with clotiapine for adults with schizophrenia." | 8.95 | Chlorpromazine versus clotiapine for schizophrenia. ( Bazrafshan, A; Esmailian, S; Goughari, AS; Mazhari, S; Shah-Esmaeili, A; Zare, M, 2017) |
| "This pooled analysis of four 6-week, randomized, open-label, parallel trials of patients with schizophrenia (Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition) compared the efficacy and tolerability of olanzapine (5-20 mg/d) with those of chlorpromazine (200-800 mg/d)." | 5.12 | Olanzapine versus chlorpromazine in the treatment of schizophrenia: a pooled analysis of four 6-week, randomized, open-label studies in the Middle East and North Africa. ( Dominguez, S; Dossenbach, M; Huang, X; Kryzhanovskaya, L; Saylan, M; Treuer, T, 2007) |
| "Patients with acute exacerbation of schizophrenia (DSM-III-R criteria; n = 158) were allocated on a random, double-blind basis to receive zotepine (150 or 300 mg/day), chlorpromazine (300 or 600 mg/day) or placebo for 8 weeks." | 5.09 | A placebo-controlled comparison of zotepine versus chlorpromazine in patients with acute exacerbation of schizophrenia. ( Butler, A; Cooper, SJ; Raniwalla, J; Tweed, J; Welch, C, 2000) |
| "We have observed two cases of chlorpromazine-induced neuroleptic malignant syndrome (NMS); both were transiently responsive to intravenous diazepam challenge, but not to blind placebo or amyobarbitol." | 5.05 | Chlorpromazine-induced neuroleptic malignant syndrome and its response to diazepam. ( Lew, TY; Tollefson, G, 1983) |
| "A four week double-blind study comparing pimozide and chlorpromazine was designed to test the hypothesis that pimozide, a powerful dopamine receptor blocker, is more effective in the treatment of acute schizophrenia than chlorpromazine." | 5.05 | Comparison of pimozide and chlorpromazine in acute schizophrenia. ( Allan, T; McClure, DJ; Pecknold, JC; Wrzesinski, L, 1982) |
| "To determine the clinical effects, safety and cost-effectiveness of chlorpromazine compared with clotiapine for adults with schizophrenia." | 4.95 | Chlorpromazine versus clotiapine for schizophrenia. ( Bazrafshan, A; Esmailian, S; Goughari, AS; Mazhari, S; Shah-Esmaeili, A; Zare, M, 2017) |
| " We have pursued evidence for the existence and nature of discontinuation syndromes following neuroleptics through reports of difficulties following the use of dopamine blocking anti-emetics, the use of chlorpromazine to treat tuberculosis, the use of antidepressant-neuroleptic combinations in affective disorders, the occurrence of tardive syndromes and studies designed to establish the existence of discontinuation syndromes in schizophrenia." | 4.80 | Neuroleptic discontinuation syndromes. ( Healy, D; Tranter, R, 1998) |
| "Three patients, aged 23-33 years, with the diagnosis of schizophrenia, developed symptoms of tardive dyskinesia while receiving neuroleptic treatment, mostly with haloperidol." | 3.65 | Diazepam in the treatment of tardive dyskinesia. Preliminary observations. ( Singh, MM, 1976) |
| "Chlorpromazine was found to be significantly better than remoxipride on the dropout rate due to inefficacy, Clinical Global Impression (CGI) of severity of illness and Brief Psychiatric Rating Scale (BPRS)." | 2.67 | A placebo-controlled clinical trial of remoxipride and chlorpromazine in newly admitted schizophrenic patients with acute exacerbation. ( Chouinard, G, 1990) |
| "Pimozide was found to exert somewhat less of an overall therapeutic effect than chlorpromazine, particularly in highly agitated patients." | 2.65 | Pimozide in the treatment of newly admitted schizophrenic patients. ( Annable, L; Chouinard, G, 1982) |
| " This study was planned to investigate changes in striatal levels of norepinephrine, dopamine and serotonin after acute and chronic administration of classical neuroleptics (haloperidol and chlorpromazine)." | 1.35 | In vivo microdialysis studies of striatal level of neurotransmitters after haloperidol and chlorpromazine administration. ( Bishnoi, M; Chopra, K; Kulkarni, SK, 2009) |
| " The present study compares the effect of chronic administration of typical and atypical antipsychotics on neurochemical profile in rat forebrain." | 1.34 | Comparative neurochemical changes associated with chronic administration of typical and atypical neuroleptics: implications in tardive dyskinesia. ( Bishnoi, M; Chopra, K; Kulkarni, SK; Kumar, A, 2007) |
| " Chronic administration of haloperidol (1 mg/kg) and chlorpromazine (5 mg/kg) resulted in a time-dependent increase in orofacial hyperkinetic movements." | 1.34 | Neurochemical changes associated with chronic administration of typical antipsychotics and its relationship with tardive dyskinesia. ( Bishnoi, M; Chopra, K; Kulkarni, SK, 2007) |
| "Risperidone (4 mg/day) was added to her drug regimen and after increasing the dosage to 6 mg/day, she began to exhibit retrocollis." | 1.31 | Tardive dystonia provoked by concomitantly administered risperidone. ( Hori, M; Hori, T; Kawanishi, Y; Shiraishi, H; Suzuki, T; Tachikawa, H, 2000) |
| "Levodopa-induced dyskinesias (LID) in Parkinson's disease (PD) may be classified into three main categories: "On" dyskinesias, diphasic dyskinesias (DD), and "off" periods." | 1.28 | Levodopa-induced dyskinesias in Parkinson's disease: clinical and pharmacological classification. ( Gershanik, O; Luquin, MR; Obeso, JA; Scipioni, O; Vaamonde, J, 1992) |
| "Of these patients, 85% experienced withdrawal symptoms, mainly insomnia, anxiety, and tensional restlessness." | 1.27 | Withdrawal symptoms after long-term treatment with low-potency neuroleptics. ( Annable, L; Bradwejn, J; Chouinard, G; Jones, BD; Ross-Chouinard, A, 1984) |
| " Such variations have been attributed to individual metabolism, pharmacologic differences, and age--all of which may need careful consideration in prescribing an appropriate dosage regimen for a given patient." | 1.27 | Interpatient variations in antipsychotic therapy. ( Gershon, S; McIntyre, IM, 1985) |
| "Relationships of neuroleptic dosage and tardive dyskinesia with measures of attentional, information-processing, and psychophysiological dysfunctions in medicated chronic schizophrenics were explored by correlational and stepwise multiple-regression analysis." | 1.27 | Relation of neuroleptic dose and tardive dyskinesia to attention, information-processing, and psychophysiology in medicated schizophrenics. ( Coyne, L; Hayes, K; Lacoursiere, R; Mazur, D; Spohn, HE, 1985) |
| "Rats with ablated frontal sensorimotor cortex and one with ablated sensorimotor connections to forebrain showed more vacuous chewing movements following 6-week chronic administration of a neuroleptic than did occipitally damaged rats or normal controls who were treated in the same way." | 1.26 | Oral dyskinesia in brain-damaged rats withdrawn from a neuroleptic: implication for models of tardive dyskinesia. ( Glassman, HN; Glassman, RB, 1980) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 60 (62.50) | 18.7374 |
| 1990's | 17 (17.71) | 18.2507 |
| 2000's | 15 (15.63) | 29.6817 |
| 2010's | 4 (4.17) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mazhari, S | 1 |
| Esmailian, S | 1 |
| Shah-Esmaeili, A | 1 |
| Goughari, AS | 1 |
| Bazrafshan, A | 1 |
| Zare, M | 1 |
| Deng, H | 1 |
| Xu, J | 1 |
| Kulkarni, SK | 5 |
| Bishnoi, M | 5 |
| Chopra, K | 5 |
| Lee, J | 1 |
| Jiang, J | 1 |
| Sim, K | 1 |
| Chong, SA | 1 |
| Kane, JM | 1 |
| Correll, CU | 1 |
| Dean, CE | 1 |
| Kuskowski, MA | 1 |
| Caligiuri, MP | 2 |
| Kumar, A | 1 |
| Dossenbach, M | 1 |
| Treuer, T | 1 |
| Kryzhanovskaya, L | 1 |
| Saylan, M | 1 |
| Dominguez, S | 1 |
| Huang, X | 1 |
| Preskorn, SH | 1 |
| Lerner, V | 1 |
| Miodownik, C | 1 |
| Kaptsan, A | 1 |
| Bersudsky, Y | 1 |
| Libov, I | 1 |
| Sela, BA | 1 |
| Witztum, E | 1 |
| Weiden, PJ | 1 |
| DeVeaugh-Geiss, J | 1 |
| Glassman, RB | 1 |
| Glassman, HN | 1 |
| Ringwald, E | 1 |
| Lustig, A | 1 |
| Moscovici, M | 1 |
| Spiegel, R | 1 |
| Vamos, E | 1 |
| Gale, K | 1 |
| Casu, M | 1 |
| Klawans, HL | 2 |
| Goetz, CG | 2 |
| Carvey, P | 2 |
| Brown, WA | 1 |
| Hollister, LE | 1 |
| Chouinard, G | 3 |
| Bradwejn, J | 1 |
| Annable, L | 2 |
| Jones, BD | 1 |
| Ross-Chouinard, A | 1 |
| Tuason, VB | 1 |
| Escobar, JI | 1 |
| Garvey, M | 1 |
| Schiele, B | 1 |
| Lew, TY | 1 |
| Tollefson, G | 1 |
| McKinney, WT | 1 |
| Moran, EC | 1 |
| Kraemer, GW | 1 |
| Prange, AJ | 1 |
| Yassa, R | 2 |
| Dimitry, R | 1 |
| Mueller, J | 1 |
| Aminoff, MJ | 1 |
| Pecknold, JC | 1 |
| McClure, DJ | 1 |
| Allan, T | 1 |
| Wrzesinski, L | 1 |
| Weiner, WJ | 1 |
| Werner, TR | 1 |
| Smith, JM | 1 |
| Burke, MP | 1 |
| Moon, CO | 1 |
| Breuning, SE | 3 |
| Ferguson, DG | 3 |
| Cullari, S | 2 |
| O'Neill, MJ | 1 |
| Risch, SC | 1 |
| Cohen, RM | 1 |
| Kalin, NH | 1 |
| Van Putten, T | 1 |
| May, PR | 1 |
| Wilkins, JN | 1 |
| Awad, AG | 1 |
| Gingell, K | 1 |
| Nadarajah, J | 1 |
| Lewander, T | 1 |
| Bollini, P | 1 |
| Pampallona, S | 1 |
| Orza, MJ | 1 |
| Adams, ME | 1 |
| Chalmers, TC | 1 |
| Tranter, R | 1 |
| Healy, D | 1 |
| Cohen, D | 1 |
| Cooper, SJ | 2 |
| Tweed, J | 1 |
| Raniwalla, J | 1 |
| Butler, A | 1 |
| Welch, C | 1 |
| Khan, M | 1 |
| Farver, D | 1 |
| Tachikawa, H | 1 |
| Suzuki, T | 1 |
| Kawanishi, Y | 1 |
| Hori, M | 1 |
| Hori, T | 1 |
| Shiraishi, H | 1 |
| Liao, DL | 1 |
| Yeh, YC | 1 |
| Chen, HM | 1 |
| Chen, H | 1 |
| Hong, CJ | 1 |
| Tsai, SJ | 1 |
| Darvesh, S | 1 |
| MacKnight, C | 1 |
| Rockwood, K | 1 |
| Quitkin, F | 2 |
| Rifkin, A | 2 |
| Gochfeld, L | 1 |
| Klein, DF | 2 |
| Lee, AS | 1 |
| Davis, JM | 1 |
| Casper, R | 1 |
| Hogarty, GE | 1 |
| Ulrich, RF | 1 |
| Kane, J | 1 |
| Struve, F | 1 |
| Rotenberg, VS | 1 |
| Arshavsky, VV | 1 |
| Guy, W | 1 |
| Petrie, W | 1 |
| Cleary, P | 1 |
| Gelenberg, AJ | 1 |
| Doller, JC | 1 |
| Bourgeois, M | 1 |
| Doongaji, DR | 1 |
| Shader, RI | 1 |
| Elkins, R | 1 |
| Ciraulo, D | 1 |
| Salzman, C | 1 |
| Levinson, P | 1 |
| Malen, R | 1 |
| Hogben, G | 1 |
| Smith, H | 1 |
| Eibergen, RD | 2 |
| Carlson, KR | 2 |
| Pfefferbaum, A | 1 |
| Berger, PA | 1 |
| Allen, RE | 1 |
| Stimmel, GL | 1 |
| Sedvall, G | 1 |
| Jeste, DV | 2 |
| Olgiati, SG | 1 |
| Ghali, AY | 1 |
| Singh, MM | 1 |
| Sandyk, R | 1 |
| Kay, SR | 2 |
| Koshino, Y | 1 |
| Madokoro, S | 1 |
| Ito, T | 1 |
| Horie, T | 1 |
| Mukai, M | 1 |
| Isaki, K | 1 |
| Luquin, MR | 1 |
| Scipioni, O | 1 |
| Vaamonde, J | 1 |
| Gershanik, O | 1 |
| Obeso, JA | 1 |
| Sachdev, P | 1 |
| Tang, WM | 1 |
| Gregory, RP | 1 |
| Smith, PT | 1 |
| Rudge, P | 1 |
| Saltz, BL | 1 |
| McClelland, HA | 1 |
| Metcalfe, AV | 1 |
| Kerr, TA | 1 |
| Dutta, D | 1 |
| Watson, P | 1 |
| Mackert, A | 1 |
| Woyth, C | 1 |
| Flechtner, KM | 1 |
| Frick, K | 1 |
| Sethi, KD | 1 |
| Hitri, A | 1 |
| Diamond, BI | 1 |
| Merriam, AE | 1 |
| Opler, LA | 1 |
| Kushner, SF | 1 |
| van Praag, HM | 1 |
| Rao, JM | 1 |
| Cowie, VA | 1 |
| Mathew, B | 1 |
| Deniker, P | 1 |
| Harris, MJ | 1 |
| Doherty, MM | 1 |
| King, DJ | 1 |
| Tanner, CM | 1 |
| McIntyre, IM | 1 |
| Gershon, S | 1 |
| Johnson, DA | 1 |
| Spohn, HE | 1 |
| Coyne, L | 1 |
| Lacoursiere, R | 1 |
| Mazur, D | 1 |
| Hayes, K | 1 |
| Trelles, L | 1 |
| Trelles, JO | 1 |
| Castaneda, C | 1 |
| Castro, C | 1 |
| Kovacic, B | 1 |
| Ruffing, D | 1 |
| Stanley, M | 1 |
| Dufresne, RL | 1 |
| Wagner, RL | 1 |
| Galdi, J | 1 |
| Bonato, RR | 1 |
| Bowers, MB | 1 |
| Swigar, ME | 1 |
| Canoso, RT | 1 |
| Romero, JA | 1 |
| Yunis, EJ | 1 |
| Chaturvedi, SK | 1 |
| Gerhardt, S | 1 |
| Gerber, R | 1 |
| Liebman, JM | 1 |
| Markianos, M | 1 |
| Tripodianakis, J | 1 |
| Addonizio, G | 1 |
12 reviews available for chlorpromazine and Dyskinesia, Drug-Induced
| Article | Year |
|---|---|
Chlorpromazine versus clotiapine for schizophrenia.
Topics: Antipsychotic Agents; Chlorpromazine; Dibenzothiazepines; Dyskinesia, Drug-Induced; Humans; Intentio | 2017 |
Wendan decoction (Traditional Chinese medicine) for schizophrenia.
Topics: Antipsychotic Agents; Chlorpromazine; Drug Therapy, Combination; Drugs, Chinese Herbal; Dyskinesia, | 2017 |
Past and present progress in the pharmacologic treatment of schizophrenia.
Topics: Antipsychotic Agents; Chlorpromazine; Clozapine; Controlled Clinical Trials as Topic; Diabetes Melli | 2010 |
Dynamic utilization of GABA in substantia nigra: regulation by dopamine and GABA in the striatum, and its clinical and behavioral implications.
Topics: 4-Aminobutyrate Transaminase; Afferent Pathways; Aminocaproates; Animals; Basal Ganglia; Behavior, A | 1981 |
Prolactin levels and effects of neuroleptics.
Topics: Antipsychotic Agents; Biological Availability; Chlorpromazine; Drug Tolerance; Dyskinesia, Drug-Indu | 1983 |
Drug treatment of schizophrenia.
Topics: Antidepressive Agents, Tricyclic; Antiparkinson Agents; Antipsychotic Agents; Chemical Phenomena; Ch | 1984 |
Neuroleptics and the neuroleptic-induced deficit syndrome.
Topics: Affective Symptoms; Antipsychotic Agents; Arousal; Chlorpromazine; Dyskinesia, Drug-Induced; Humans; | 1994 |
Antipsychotic drugs: is more worse? A meta-analysis of the published randomized control trials.
Topics: Antipsychotic Agents; Chlorpromazine; Chronic Disease; Dose-Response Relationship, Drug; Dyskinesia, | 1994 |
Neuroleptic discontinuation syndromes.
Topics: Antiemetics; Antipsychotic Agents; Chlorpromazine; Dyskinesia, Drug-Induced; Humans; Mood Disorders; | 1998 |
Rapid resolution of antipsychotic-induced tardive dyskinesia with olanzapine.
Topics: Aged; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Chlorpromazine; Chronic Disease; Dysk | 2000 |
Antipsychotic drugs: clinical pharmacology and therapeutic use.
Topics: Antipsychotic Agents; Chlorpromazine; Clinical Trials as Topic; Dose-Response Relationship, Drug; Do | 1977 |
Antipsychotic medication: clinical guidelines for maintenance therapy.
Topics: Administration, Oral; Ambulatory Care; Anti-Anxiety Agents; Antipsychotic Agents; Basal Ganglia Dise | 1985 |
16 trials available for chlorpromazine and Dyskinesia, Drug-Induced
| Article | Year |
|---|---|
Olanzapine versus chlorpromazine in the treatment of schizophrenia: a pooled analysis of four 6-week, randomized, open-label studies in the Middle East and North Africa.
Topics: Adolescent; Adult; Africa, Northern; Antipsychotic Agents; Benzodiazepines; Chlorpromazine; Dyskines | 2007 |
Vitamin B6 treatment for tardive dyskinesia: a randomized, double-blind, placebo-controlled, crossover study.
Topics: Adult; Aged; Antipsychotic Agents; Basal Ganglia Diseases; Chlorpromazine; Cross-Over Studies; Doubl | 2007 |
Loxapine versus chlorpromazine in paranoid schizophrenia: a double-blind study.
Topics: Adult; Basal Ganglia Diseases; Chlorpromazine; Clinical Trials as Topic; Dibenzoxazepines; Dizziness | 1984 |
Chlorpromazine-induced neuroleptic malignant syndrome and its response to diazepam.
Topics: Brain; Chlorpromazine; Diazepam; Dopamine; Dyskinesia, Drug-Induced; Dystonia; Female; Fever; gamma- | 1983 |
Pimozide in the treatment of newly admitted schizophrenic patients.
Topics: Acute Disease; Adult; Chlorpromazine; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Humans; | 1982 |
Comparison of pimozide and chlorpromazine in acute schizophrenia.
Topics: Acute Disease; Adult; Chlorpromazine; Clinical Trials as Topic; Double-Blind Method; Dyskinesia, Dru | 1982 |
A placebo-controlled comparison of zotepine versus chlorpromazine in patients with acute exacerbation of schizophrenia.
Topics: Acute Disease; Adolescent; Adult; Antipsychotic Agents; Chlorpromazine; Dibenzothiepins; Dose-Respon | 2000 |
Association between the Ser9Gly polymorphism of the dopamine D3 receptor gene and tardive dyskinesia in Chinese schizophrenic patients.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Chlorpromazine; DNA; Dyskinesia, Drug-Induced; Female | 2001 |
Antipsychotic drugs: clinical pharmacology and therapeutic use.
Topics: Antipsychotic Agents; Chlorpromazine; Clinical Trials as Topic; Dose-Response Relationship, Drug; Do | 1977 |
Temporal effects of drug and placebo in delaying relapse in schizophrenic outpatients.
Topics: Aftercare; Chlorpromazine; Clinical Trials as Topic; Dyskinesia, Drug-Induced; Humans; Longitudinal | 1977 |
Are prophylactic antiparkinson drugs necessary? A controlled study of procyclidine withdrawal.
Topics: Adult; Aftercare; Bipolar Disorder; Chlorpromazine; Clinical Trials as Topic; Double-Blind Method; D | 1978 |
The incidence of treatment emergent symptoms under chlorpromazine and placebo conditions [proceedings].
Topics: Adult; Chlorpromazine; Clinical Trials as Topic; Dyskinesia, Drug-Induced; Female; Humans; Male; Pla | 1978 |
Clozapine versus chlorpromazine for the treatment of schizophrenia: preliminary results from a double-blind study.
Topics: Adult; Aged; Chlorpromazine; Clinical Trials as Topic; Clozapine; Dibenzazepines; Double-Blind Metho | 1979 |
A placebo-controlled clinical trial of remoxipride and chlorpromazine in newly admitted schizophrenic patients with acute exacerbation.
Topics: Acute Disease; Adolescent; Adult; Antipsychotic Agents; Benzamides; Chlorpromazine; Clonazepam; Dose | 1990 |
Tardive dystonia. The benefits of time.
Topics: Adult; Chlorpromazine; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Dys | 1989 |
Relationship of adverse drug reactions to length of hospital-stay in genetically subgrouped schizophrenics.
Topics: Antipsychotic Agents; Chlorpromazine; Clinical Trials as Topic; Depressive Disorder; Double-Blind Me | 1988 |
69 other studies available for chlorpromazine and Dyskinesia, Drug-Induced
| Article | Year |
|---|---|
In vivo microdialysis studies of striatal level of neurotransmitters after haloperidol and chlorpromazine administration.
Topics: Animals; Antipsychotic Agents; Basal Ganglia; Behavior, Animal; Catalepsy; Chlorpromazine; Corpus St | 2009 |
The prevalence of tardive dyskinesia in Chinese Singaporean patients with schizophrenia: revisited.
Topics: Adult; Aged; Antipsychotic Agents; Asian People; Chlorpromazine; Dyskinesia, Drug-Induced; Female; H | 2010 |
Predictors of neuroleptic-induced dyskinesia and parkinsonism: the influence of measurement methods and definitions.
Topics: Adult; Age Distribution; Age Factors; Aged; Aging; Antipsychotic Agents; Chlorpromazine; Craniocereb | 2006 |
Comparative neurochemical changes associated with chronic administration of typical and atypical neuroleptics: implications in tardive dyskinesia.
Topics: Animals; Antipsychotic Agents; Body Weight; Chlorpromazine; Clozapine; Dopamine; Dyskinesia, Drug-In | 2007 |
Possible anti-oxidant and neuroprotective mechanisms of zolpidem in attenuating typical anti-psychotic-induced orofacial dyskinesia: a biochemical and neurochemical study.
Topics: Animals; Anti-Dyskinesia Agents; Antioxidants; Antipsychotic Agents; Catalase; Chlorpromazine; Diaze | 2007 |
Neurochemical changes associated with chronic administration of typical antipsychotics and its relationship with tardive dyskinesia.
Topics: Animals; Antipsychotic Agents; Behavior, Animal; Brain; Chlorpromazine; Dopamine; Dyskinesia, Drug-I | 2007 |
The evolution of antipsychotic drug therapy: reserpine, chlorpromazine, and haloperidol.
Topics: Antipsychotic Agents; Chlorpromazine; Dyskinesia, Drug-Induced; Europe; Haloperidol; History, 20th C | 2007 |
U-74500A (lazaroid), a 21-aminosteroid attenuates neuroleptic-induced orofacial dyskinesia.
Topics: Animals; Antioxidants; Antipsychotic Agents; Chlorpromazine; Disease Models, Animal; Dyskinesia, Dru | 2007 |
Antipsychotic-induced movement disorders - forgotten but not gone.
Topics: Akathisia, Drug-Induced; Antipsychotic Agents; Brain; Chlorpromazine; Clozapine; Dopamine; Dyskinesi | 2008 |
Tardive Tourette syndrome.
Topics: Aged; Antipsychotic Agents; Chlorpromazine; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Hum | 1980 |
Oral dyskinesia in brain-damaged rats withdrawn from a neuroleptic: implication for models of tardive dyskinesia.
Topics: Amphetamine; Animals; Antipsychotic Agents; Apomorphine; Behavior, Animal; Brain; Chlorpromazine; Di | 1980 |
[Effect of high single doses of bromocriptine in schizophrenic patients with elevated serum prolactin levels and extrapyramidal side effects associated with neuroleptic treatment (author's transl)].
Topics: Adult; Antipsychotic Agents; Bromocriptine; Chlorpromazine; Chronic Disease; Dose-Response Relations | 1980 |
Animal models of tardive dyskinesias.
Topics: Animals; Antipsychotic Agents; Apomorphine; Chlorpromazine; Disease Models, Animal; Dyskinesia, Drug | 1983 |
Withdrawal symptoms after long-term treatment with low-potency neuroleptics.
Topics: Adult; Akathisia, Drug-Induced; Ambulatory Care; Antipsychotic Agents; Anxiety Disorders; Chlorproma | 1984 |
Long-term chlorpromazine in rhesus monkeys: production of dyskinesias and changes in social behavior.
Topics: Aggression; Animals; Chlorpromazine; Dyskinesia, Drug-Induced; Hand; Humans; Macaca mulatta; Mouth; | 1980 |
Single phenothiazines and tardive dyskinesia.
Topics: Aged; Chlorpromazine; Dyskinesia, Drug-Induced; Female; Humans; Middle Aged; Thioridazine; Trifluope | 1983 |
Tourette-like syndrome after long-term neuroleptic drug treatment.
Topics: Adult; Chlorpromazine; Dyskinesia, Drug-Induced; Haloperidol; Humans; Male; Substance Withdrawal Syn | 1982 |
Mania-induced remission of tardive dyskinesia in manic-depressive illness.
Topics: Adult; Bipolar Disorder; Chlorpromazine; Dyskinesia, Drug-Induced; Haloperidol; Humans; Male; Remiss | 1982 |
Long-term changes in AIMS ratings and their relation to medication history [proceedings].
Topics: Age Factors; Aged; Chlorpromazine; Dyskinesia, Drug-Induced; Female; Humans; Male; Middle Aged; Schi | 1981 |
Analysis of single, double-blind procedures, maintenance of placebo effects, and drug-induced dyskinesia with mentally retarded persons--a brief report [proceedings].
Topics: Adolescent; Adult; Aged; Chlorpromazine; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Halo | 1981 |
Analysis of single-double blind procedures, maintenance of placebo effects and drug induced dyskinesia with mentally retarded persons.
Topics: Adult; Aged; Chlorpromazine; Double-Blind Method; Drug Evaluation; Dyskinesia, Drug-Induced; Female; | 1980 |
Comparison of psychotropic drug, response cost, and psychotropic drug plus response cost procedures for controlling institutionalized mentally retarded persons.
Topics: Adolescent; Adult; Aged; Behavior Therapy; Chlorpromazine; Double-Blind Method; Dyskinesia, Drug-Ind | 1980 |
Propranolol, chlorpromazine, and tardive dyskinesia.
Topics: Biological Availability; Chlorpromazine; Drug Interactions; Dyskinesia, Drug-Induced; Propranolol | 1980 |
Importance of akinesia: plasma chlorpromazine and prolactin levels.
Topics: Adult; Affective Symptoms; Chlorpromazine; Dyskinesia, Drug-Induced; Humans; Prolactin; Schizophreni | 1980 |
Subjective response to neuroleptics in schizophrenia.
Topics: Adult; Affective Symptoms; Antipsychotic Agents; Chlorpromazine; Dyskinesia, Drug-Induced; Female; H | 1993 |
A controlled community study of movement disorder in people with learning difficulties on anti-psychotic medication.
Topics: Adult; Antipsychotic Agents; Chlorpromazine; Diagnosis, Differential; Dose-Response Relationship, Dr | 1994 |
What is appropriate disclosure?
Topics: Adult; Age Factors; Aged; Antipsychotic Agents; Chlorpromazine; Dyskinesia, Drug-Induced; Humans; In | 1999 |
Tardive dystonia provoked by concomitantly administered risperidone.
Topics: Adolescent; Antipsychotic Agents; Chlorpromazine; Drug Therapy, Combination; Dyskinesia, Drug-Induce | 2000 |
Butyrylcholinesterase and cognitive function.
Topics: Adult; Brain; Butyrylcholinesterase; Chlorpromazine; Cholinergic Antagonists; Cognition Disorders; D | 2001 |
Tardive dyskinesia: are first signs reversible?
Topics: Adult; Antipsychotic Agents; Chlorpromazine; Dyskinesia, Drug-Induced; Female; Fluphenazine; Haloper | 1977 |
Drug-induced dystonic reactions.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Chlorpromazine; Dyskinesia, Drug-Induced; Female; Hum | 1977 |
Search activity and its impact on experimental and clinical pathology.
Topics: Acoustic Stimulation; Alcoholism; Animals; Anxiety; Brain Mapping; Chlorpromazine; Dyskinesia, Drug- | 1979 |
[Tardive Dyskinesia induced by neuroleptics: a survey of 3140 patients in a psychiatric hospital].
Topics: Aged; Antiparkinson Agents; Basal Ganglia Diseases; Chlorpromazine; Diagnosis, Differential; Dyskine | 1977 |
The treatment of tardive dyskinesia with penfluridol. A case report.
Topics: Adult; Chlorpromazine; Dyskinesia, Drug-Induced; Humans; Male; Penfluridol; Piperidines; Trifluopera | 1977 |
On guidelines for maximum dosages.
Topics: Chlorpromazine; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Humans; Middle Aged; Tra | 1978 |
Psychological factors in susceptibility to drug-induced extrapyramidal symptoms.
Topics: Adult; Basal Ganglia Diseases; Chlorpromazine; Dose-Response Relationship, Drug; Dyskinesia, Drug-In | 1978 |
Dyskinesias in monkeys: interaction of methamphetamine with prior methadone treatment.
Topics: Animals; Chlorpromazine; Clozapine; Diazepam; Dyskinesia, Drug-Induced; Haloperidol; Haplorhini; Hum | 1976 |
Susceptibility to amphetamine-elicited dyskinesias following chronic methadone treatment in monkeys.
Topics: Animals; Chlorpromazine; Clozapine; Diazepam; Drug Interactions; Dyskinesia, Drug-Induced; Haloperid | 1976 |
Narcolepsy, paranoid psychosis, and tardive dyskinesia: a pharmacological dilemma.
Topics: Chlorpromazine; Dyskinesia, Drug-Induced; Fluphenazine; Humans; Imipramine; Male; Middle Aged; Narco | 1977 |
Neuroleptic dosage, duration, and tardive dyskinesia.
Topics: Adult; Chlorpromazine; Dyskinesia, Drug-Induced; Female; Humans; Middle Aged; Receptors, Dopamine; T | 1977 |
[Treatment of schizophrenia. Clinical pharmacological viewpoint].
Topics: Chlorpromazine; Drug Evaluation; Dyskinesia, Drug-Induced; Humans; Schizophrenia | 1977 |
Masking of tardive dyskinesia with four times-a-day administration of chlorpromazine.
Topics: Adult; Chlorpromazine; Drug Administration Schedule; Dyskinesia, Drug-Induced; Female; Humans; Schiz | 1977 |
Diazepam in the treatment of tardive dyskinesia. Preliminary observations.
Topics: Adult; Chlorpromazine; Diazepam; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Male; Schizo | 1976 |
"Positive" and "negative" movement disorders in schizophrenia.
Topics: Adult; Chlorpromazine; Dyskinesia, Drug-Induced; Female; Humans; Male; Parkinson Disease, Secondary; | 1992 |
A survey of tardive dyskinesia in psychiatric inpatients in Japan.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antipsychotic Agents; Chlorpromazine; Dyski | 1992 |
Levodopa-induced dyskinesias in Parkinson's disease: clinical and pharmacological classification.
Topics: Aged; Apomorphine; Chlorpromazine; Dopamine Agents; Dose-Response Relationship, Drug; Dyskinesia, Dr | 1992 |
Psychotic symptoms preceding ocular deviation in a patient with tardive oculogyric crises.
Topics: Adult; Antipsychotic Agents; Benztropine; Chlorpromazine; Dose-Response Relationship, Drug; Dyskines | 1992 |
Tardive dyskinesia presenting as severe dysphagia.
Topics: Bipolar Disorder; Chlorpromazine; Deglutition Disorders; Dyskinesia, Drug-Induced; Female; Flupenthi | 1992 |
Tardive dyskinesia in the elderly patient.
Topics: Aged; Chlorpromazine; Chronic Disease; Clonazepam; Clozapine; Depressive Disorder; Desipramine; Diph | 1992 |
Facial dyskinesia: a 16-year follow-up study.
Topics: Affective Disorders, Psychotic; Aged; Antipsychotic Agents; Brain; Chlorpromazine; Dose-Response Rel | 1991 |
[Increased blink rate in schizophrenic patients].
Topics: Adult; Antipsychotic Agents; Blinking; Chlorpromazine; Dose-Response Relationship, Drug; Dyskinesia, | 1990 |
Phenytoin potentiation of neuroleptic-induced dyskinesias.
Topics: Animals; Chlorpromazine; Corpus Striatum; Drug Synergism; Dyskinesia, Drug-Induced; Male; Phenytoin; | 1990 |
Neurological signs and the positive-negative dimension in schizophrenia.
Topics: Adult; Chlorpromazine; Chronic Disease; Dyskinesia, Drug-Induced; Frontal Lobe; Humans; Male; Neuroc | 1990 |
Neuroleptic-induced parkinsonian side effects in the mentally handicapped.
Topics: Adult; Antipsychotic Agents; Chlorpromazine; Dyskinesia, Drug-Induced; Female; Humans; Intellectual | 1989 |
From chlorpromazine to tardive dyskinesia (brief history of the neuroleptics).
Topics: Antipsychotic Agents; Chlorpromazine; Dyskinesia, Drug-Induced; France; History, 20th Century; Human | 1989 |
Instrumental assessment of lingual motor instability in tardive dyskinesia.
Topics: Antipsychotic Agents; Chlorpromazine; Dyskinesia, Drug-Induced; Humans; Movement; Tongue | 1989 |
The pathophysiology of tardive dyskinesia.
Topics: Animals; Antipsychotic Agents; Apomorphine; Behavior, Animal; Chlorpromazine; Corpus Striatum; Disea | 1985 |
Interpatient variations in antipsychotic therapy.
Topics: Age Factors; Antipsychotic Agents; Basal Ganglia Diseases; Chlorpromazine; Dose-Response Relationshi | 1985 |
Relation of neuroleptic dose and tardive dyskinesia to attention, information-processing, and psychophysiology in medicated schizophrenics.
Topics: Adolescent; Adult; Antipsychotic Agents; Attention; Chlorpromazine; Chronic Disease; Dyskinesia, Dru | 1985 |
[Disappearance of tardive dyskinesia in a manic attack].
Topics: Aged; Bipolar Disorder; Chlorpromazine; Dyskinesia, Drug-Induced; Humans; Male; Neurotransmitter Age | 1985 |
Effect of neuroleptics and of potential new antipsychotic agents (MJ 13859-1 and MJ 13980-1) on a monkey model of tardive dyskinesia.
Topics: Animals; Antipsychotic Agents; Cebus; Chlorpromazine; Clozapine; Dyskinesia, Drug-Induced; Female; H | 1986 |
Antipsychotic-withdrawal akathisia versus antipsychotic-induced akathisia: further evidence for the existence of tardive akathisia.
Topics: Adult; Akathisia, Drug-Induced; Ambulatory Care; Antipsychotic Agents; Basal Ganglia Diseases; Chlor | 1988 |
Psychotic patients who become worse on neuroleptics.
Topics: Adolescent; Adult; Antipsychotic Agents; Benztropine; Chlorpromazine; Dyskinesia, Drug-Induced; Fema | 1988 |
Immunogenetic markers in chlorpromazine-induced tardive dyskinesia.
Topics: Antibodies, Antinuclear; Blood Coagulation Factors; Chlorpromazine; Chronic Disease; Dyskinesia, Dru | 1986 |
Piracetam for drug-induced dyskinesia.
Topics: Adult; Bipolar Disorder; Chlorpromazine; Dyskinesia, Drug-Induced; Female; Humans; Piracetam; Pyrrol | 1987 |
SCH 23390 dissociated from conventional neuroleptics in apomorphine climbing and primate acute dyskinesia models.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Benzazepines; Benz | 1985 |
Low plasma dopamine-beta-hydroxylase in demented schizophrenics.
Topics: Chlorpromazine; Chronic Disease; Dementia; Dopamine beta-Hydroxylase; Dose-Response Relationship, Dr | 1985 |
The Pisa syndrome: a report of two cases.
Topics: Adult; Chlorpromazine; Dyskinesia, Drug-Induced; Dystonia; Gait; Humans; Male; Middle Aged; Paranoid | 1985 |
Rapid induction of extrapyramidal side effects with combined use of lithium and neuroleptics.
Topics: Adult; Chlorpromazine; Drug Interactions; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Femal | 1985 |